PMC:7335494 / 27813-28003 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T18","span":{"begin":113,"end":120},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"}],"text":" slight decrease of IL-10 and CRP Ampatzoglou et al. (2016)\nObservational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fa"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T216","span":{"begin":113,"end":120},"obj":"Body_part"}],"attributes":[{"id":"A216","pred":"fma_id","subj":"T216","obj":"http://purl.org/sig/ont/fma/fma82743"}],"text":" slight decrease of IL-10 and CRP Ampatzoglou et al. (2016)\nObservational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fa"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T308","span":{"begin":20,"end":22},"obj":"Chemical"},{"id":"T310","span":{"begin":113,"end":120},"obj":"Chemical"}],"attributes":[{"id":"A308","pred":"chebi_id","subj":"T308","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A309","pred":"chebi_id","subj":"T308","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A310","pred":"chebi_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A311","pred":"chebi_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"}],"text":" slight decrease of IL-10 and CRP Ampatzoglou et al. (2016)\nObservational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fa"}

{"project":"MyTest","denotations":[{"id":"32640331-25618418-30720813","span":{"begin":54,"end":58},"obj":"25618418"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":" slight decrease of IL-10 and CRP Ampatzoglou et al. (2016)\nObservational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fa"}

{"project":"2_test","denotations":[{"id":"32640331-25618418-30720813","span":{"begin":54,"end":58},"obj":"25618418"}],"text":" slight decrease of IL-10 and CRP Ampatzoglou et al. (2016)\nObservational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fa"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T2054","span":{"begin":20,"end":22},"obj":"PR:000001395"},{"id":"T2055","span":{"begin":22,"end":25},"obj":"PR:000001395;GO:1990774"}],"text":" slight decrease of IL-10 and CRP Ampatzoglou et al. (2016)\nObservational study 8 subjects with impaired fasting glucose subjects received (1) high-fibre formula; (2) high-monounsaturated fa"}